clorazepate sold brand name tranxene among others benzodiazepine medication possesses anxiolytic anticonvulsant sedative hypnotic skeletal muscle relaxant properties clorazepate unusually longlasting benzodiazepine serves prodrug equally longlasting desmethyldiazepam rapidly produced active metabolite desmethyldiazepam responsible therapeutic effects patented approved medical use clorazepate used treatment anxiety disorders insomnia may also prescribed anticonvulsant muscle also used clorazepate prescribed principally treatment alcohol withdrawal epilepsy although also useful anxiolytic long halflife normal starting dosage range clorazepate mg per day drug taken two four times per day dosages high mg per day may used treatment acute alcohol withdrawal united states canada clorazepate available mg capsules tablets europe tablet formations mg mg mg clorazepate sd controlled release available may reduced incidence adverse effects sustainedrelease formulation clorazepate advantages dose missed less profound fluctuations blood plasma levels occur may helpful people epilepsy risk breakthrough adverse effects clorazepate include tolerance dependence withdrawal reactions cognitive impairment confusion anterograde amnesia falls elderly ataxia hangover effects drowsiness unclear whether cognitive deficits resulting longterm use benzodiazepines return normal persist indefinitely withdrawal benzodiazepinescitation needed benzodiazepines also known cause worsen depression paradoxical effects including excitement paradoxical worsening seizures sometimes result use benzodiazepines children elderly individuals history alcohol use disorder history aggressive behavior anger greater risk developing paradoxical reactions september us food drug administration fda required boxed warning updated benzodiazepine medicines describe risks nonmedical use addiction physical dependence withdrawal reactions consistently across medicines delirium noted discontinuation benzodiazepine dependence occurs approximately one third patients take benzodiazepines longer weeks characterised withdrawal syndrome upon dose reduction used seizure control tolerance may manifest increased rate seizures well increased risk withdrawal seizures humans tolerance anticonvulsant effects clorazepate occurs frequently regular use due development tolerance benzodiazepines general considered appropriate longterm management epilepsy increasing dose may result developing tolerance higher dose combined worsened adverse effects crosstolerance occurs benzodiazepines meaning individuals tolerant one benzodiazepine display tolerance equivalent doses benzodiazepines withdrawal symptoms benzodiazepines include worsening preexisting symptoms well appearance new symptoms preexisting withdrawal symptoms may range mild anxiety insomnia severe withdrawal symptoms seizures psychosis withdrawal symptoms difficult cases differentiate preexisting symptoms withdrawal symptoms use high doses longterm use abrupt overrapid withdrawal increases increase severity withdrawal however tolerance active metabolite clorazepate may occur slowly regular use benzodiazepines causes development dependence characterised tolerance therapeutic effects benzodiazepines development benzodiazepine withdrawal syndrome including symptoms anxiety apprehension tremor insomnia nausea vomiting upon cessation benzodiazepine use withdrawal benzodiazepines gradual abrupt withdrawal high doses benzodiazepines may cause confusion toxic psychosis convulsions condition resembling delirium tremens abrupt withdrawal lower doses may cause depression nervousness rebound insomnia irritability sweating sedatives hypnotics eg benzodiazepines barbiturates antiepileptic drugs alcohol antihistamines opioids neuroleptics sleep aids likely magnify effects clorazepate central nervous system drugs may interact clorazepate include digoxin disulfiram fluoxetine isoniazid ketoconazole levodopa metoprolol hormonal contraceptives probenecid propranolol rifampin theophylline valproic selective serotonin reuptake inhibitors cimetidine macrolide antibiotics antimycotics inhibit metabolism benzodiazepines may result increased plasma levels resultant enhancement adverse effects phenytoin phenobarbital carbamazepine opposite effect coadministration leading increased metabolism decreased therapeutic effects benzodiazepines require special precaution used elderly children alcohol drugdependent individuals individuals comorbid psychiatric clorazepate used late pregnancy third trimester causes definite risk severe benzodiazepine withdrawal syndrome neonate symptoms including hypotonia reluctance suck apnoeic spells cyanosis impaired metabolic responses cold stress floppy infant syndrome sedation newborn may also occur symptoms floppy infant syndrome neonatal benzodiazepine withdrawal syndrome reported persist hours months special precaution required using clorazepate elderly elderly metabolise clorazepate slowly may result excessive drug accumulation additionally elderly sensitive adverse effects benzodiazepines compared younger individuals even blood plasma levels use benzodiazepines elderly recommended weeks also recommended half usual daily dose clorazepate classical benzodiazepine classical benzodiazepines include chlordiazepoxide diazepam clonazepam oxazepam lorazepam nitrazepam bromazepam clorazepate longacting benzodiazepine clorazepate produces active metabolite desmethyldiazepam partial agonist gabaa receptor half life hours small amount desmethyldiazepam metabolised oxazepam clorazepate exerts pharmacological properties via increasing opening frequency chloride ion channel gabaa receptors effect benzodiazepines requires presence neurotransmitter gaba results enhanced inhibitory effects neurotransmitter gaba acting gabaa clorazepate like benzodiazepines widely distributed highly bound plasma proteins clorazepate also crosses readily placenta breast milk peak plasma levels active metabolite desmethyldiazepam seen minutes hours oral administration clorazepate clorazepate completely metabolised desmethyldiazepam gastrointestinal tract thus pharmacological properties clorazepate largely due clorazepate used form dipotassium salt unusual among benzodiazepines freely soluble water clorazepate synthesized starting upon reaction phenylmagnesium bromide transformed reacting aminomalonic ester gives heterocyclization product upon hydrolysis using alcoholic solution potassium hydroxide forms dipotassium salt chlorazepate united states clorazepate listed schedule iv controlled substances act httpsenwikipediaorgwikiclorazepate